Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMUS: Ultra-short Course of Primaquine for Vivax Malaria
NCT07468526Phase 3Not yet recruiting
- Sponsor
- Menzies School of Health Research
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of primaquine in malaria, sponsored by Menzies School of Health Research. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07468526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07468526.